Engemycin Spray - 200ml

A broad-spectrum Oxytetracycline injection useful in treating a wide range of infections in horses, cattle, sheep or pigs.

Engemycin 10% (DD) can be administered either at a low dose rate for a 24 hour duration of activity or at a high dose rate for prolonged duration of activity.

In vitro, oxytetracycline is active against a range of both Gram-positive and Gram-negative microorganisms including: Streptococcus spp., Staphylococcus spp., Listeria monocytogenes, Mannheimia haemolytica, Haemophilus parahaemolyticus, Bordetella bronchiseptica, and against Chlamydophila abortus (formerly Chlamydia psittaci), the causative organism of enzootic abortion in sheep..

Active ingredient: Oxytetracycline

Repiderma is a protective hoof and dermal spray that gives visible results after the 1st day! With its unique and patented formulation, Intra Repiderma is unlike any other spray in the market. By spraying micronized organic powder minerals, Intra Repiderma forms a protective layer which has a very strong adhesion to provide the optimal contact time to the hooves and skin. Last but not least, the product is safe to use for the farmer, the animal and the environment.

- Patented antibiotic free product
- Protective layer for the hooves and skin
- Strong adhesion, for at least 3 days
- Sprays in every angle, even upside down
- 80-100 applications: hoof, udder cleft, dehorning, navel and skin care

250ml can

Strong Iodine Solution 10% is a general disinfectant that helps fight bacteria and germs. Bacterial spores are killed within 15 minutes of use. Can also be used to treat animal wounds.

For the active immunisation of cattle against
• Parainfluenza3 virus (PI3 virus), to reduce infections.
• Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs.
• Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the A6 serotype of M. haemolytica has been demonstrated in a challenge experiment under laboratory conditions after a primary course of vaccination.

Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against BRS-Virus and PI3-Virus is at its highest level.

The duration of protective immunity has not been established in challenge experiments.

Dosage & Administration:
Vaccination dose: 5 ml by subcutaneous injection at the side of the neck.